lilly retatrutide trial BEYOND OZEMPIC: ELI WEIGHT LOSS TRIALS Clinical results for Eli Lilly's retatrutide show adults losing up to 30 percent of their body weight, far outperforming current options. https://blkcosmo.com/ retatrutide-weight-loss-trials Eli Lilly's Retatrutide Achieves 28%
Description
You will receive a personalized prescription weight loss plan curated by licensed professionals
Retatrutide is the first drug to target receptors for three hormones: GLP-1, GIP, and glucagon
They are not cheap
GLP-1 is secreted from L-cells in the distal ileum and colon in response to meals [14]
Nausea and vomiting are the most common, followed by diarrhea and stomach pain
